| 2018 ESC guidelines for the management of cardiovascular diseases during pregnancy: the task force for the management of cardiovascular diseases during pregnancy of the … V Regitz-Zagrosek, JW Roos-Hesselink, J Bauersachs, ... European heart journal 39 (34), 3165-3241, 2018 | 4427 | 2018 |
| Laminin–A glycoprotein from basement membranes. R Timpl, H Rohde, PG Robey, SI Rennard, JM Foidart, GR Martin Journal of Biological Chemistry 254 (19), 9933-9937, 1979 | 3006 | 1979 |
| Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions P Carmeliet, L Moons, A Luttun, V Vincenti, V Compernolle, M De Mol, ... Nature medicine 7 (5), 575-583, 2001 | 2201 | 2001 |
| Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid J Wood, K Bonjean, S Ruetz, A Bellahcène, L Devy, JM Foidart, ... Journal of Pharmacology and Experimental Therapeutics 302 (3), 1055-1061, 2002 | 1188 | 2002 |
| Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization K Bajou, A Noël, RD Gerard, V Masson, N Brunner, C Holst-Hansen, ... Nature medicine 4 (8), 923-928, 1998 | 873 | 1998 |
| Enzyme-linked immunoassay (ELISA) for connective tissue components SI Rennard, R Berg, GR Martin, JM Foidart, PG Robey Analytical Biochemistry 104 (1), 205-214, 1980 | 698 | 1980 |
| Distribution and immunoelectron microscopic localization of laminin, a noncollagenous basement membrane glycoprotein. JM Foidart, EW Bere Jr, M Yaar, SI Rennard, M Gullino, GR Martin, SI Katz Laboratory investigation; a journal of technical methods and pathology 42 (3 …, 1980 | 679 | 1980 |
| Overexpression of the soluble vascular endothelial growth factor receptor in preeclamptic patients: pathophysiological consequences V Tsatsaris, F Goffin, C Munaut, JF Brichant, MR Pignon, A Noel, ... The Journal of Clinical Endocrinology & Metabolism 88 (11), 5555-5563, 2003 | 640 | 2003 |
| Is planned vaginal delivery for breech presentation at term still an option? Results of an observational prospective survey in France and Belgium F Goffinet, M Carayol, JM Foidart, S Alexander, S Uzan, D Subtil, G Bréart, ... American journal of obstetrics and gynecology 194 (4), 1002-1011, 2006 | 616 | 2006 |
| Antibodies to type II collagen in relapsing polychondritis JM Foidart, S Abe, GR Martin, TM Zizic, EV Barnett, TJ Lawley, SI Katz New England Journal of Medicine 299 (22), 1203-1207, 1978 | 573 | 1978 |
| Histone deacetylases inhibitors as anti-angiogenic agents altering vascular endothelial growth factor signaling CF Deroanne, K Bonjean, S Servotte, L Devy, A Colige, N Clausse, ... Oncogene 21 (3), 427-436, 2002 | 526 | 2002 |
| Safety and efficacy of tibolone in breast-cancer patients with vasomotor symptoms: a double-blind, randomised, non-inferiority trial P Kenemans, NJ Bundred, JM Foidart, E Kubista, B von Schoultz, ... The lancet oncology 10 (2), 135-146, 2009 | 490 | 2009 |
| Transactivation of vimentin by β-catenin in human breast cancer cells C Gilles, M Polette, M Mestdagt, B Nawrocki-Raby, P Ruggeri, ... Cancer research 63 (10), 2658-2664, 2003 | 482 | 2003 |
| Vascular endothelial growth factor expression correlates with matrix metalloproteinases MT1‐MMP, MMP‐2 and MMP‐9 in human glioblastomas C Munaut, A Noël, O Hougrand, JM Foidart, J Boniver, M Deprez International journal of cancer 106 (6), 848-855, 2003 | 429 | 2003 |
| Placental growth factor, a member of the VEGF family, contributes to the development of choroidal neovascularization JM Rakic, V Lambert, L Devy, A Luttun, P Carmeliet, C Claes, L Nguyen, ... Investigative ophthalmology & visual science 44 (7), 3186-3193, 2003 | 422 | 2003 |
| The plasminogen activator inhibitor PAI-1 controls in vivo tumor vascularization by interaction with proteases, not vitronectin: implications for antiangiogenic strategies K Bajou, V Masson, RD Gerard, PM Schmitt, V Albert, M Praus, LR Lund, ... The Journal of cell biology 152 (4), 777-784, 2001 | 421 | 2001 |
| Laser-induced choroidal neovascularization model to study age-related macular degeneration in mice V Lambert, J Lecomte, S Hansen, S Blacher, MLA Gonzalez, I Struman, ... Nature protocols 8 (11), 2197-2211, 2013 | 406 | 2013 |
| Matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs in the respiratory tract: potential implications in asthma and other lung diseases MM Gueders, JM Foidart, A Noel, DD Cataldo European journal of pharmacology 533 (1-3), 133-144, 2006 | 400 | 2006 |
| Vimentin contributes to human mammary epithelial cell migration C Gilles, M Polette, JM Zahm, JM Tournier, L Volders, JM Foidart, ... Journal of cell science 112 (24), 4615-4625, 1999 | 392 | 1999 |
| In vivo evidence that the stromelysin-3 metalloproteinase contributes in a paracrine manner to epithelial cell malignancy R Masson, O Lefebvre, A Noël, ME Fahime, MP Chenard, C Wendling, ... The Journal of cell biology 140 (6), 1535-1541, 1998 | 377 | 1998 |
